nodes	percent_of_prediction	percent_of_DWPC	metapath
Perphenazine—CYP1A2—chronic obstructive pulmonary disease	0.234	0.542	CbGaD
Perphenazine—HTR2A—chronic obstructive pulmonary disease	0.198	0.458	CbGaD
Perphenazine—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0314	0.0921	CbGbCtD
Perphenazine—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0314	0.0921	CbGbCtD
Perphenazine—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0284	0.0832	CbGbCtD
Perphenazine—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0261	0.0765	CbGbCtD
Perphenazine—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0261	0.0765	CbGbCtD
Perphenazine—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0246	0.0722	CbGbCtD
Perphenazine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0239	0.07	CbGbCtD
Perphenazine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0239	0.07	CbGbCtD
Perphenazine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0213	0.0624	CbGbCtD
Perphenazine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.02	0.0587	CbGbCtD
Perphenazine—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0198	0.058	CbGbCtD
Perphenazine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0135	0.0397	CbGbCtD
Perphenazine—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0132	0.0387	CbGbCtD
Perphenazine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0129	0.0378	CbGbCtD
Perphenazine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0115	0.0337	CbGbCtD
Perphenazine—HTR2A—phrenic nerve—chronic obstructive pulmonary disease	0.00771	0.188	CbGeAlD
Perphenazine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00675	0.0198	CbGbCtD
Perphenazine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00637	0.0187	CbGbCtD
Perphenazine—HTR7—pulmonary artery—chronic obstructive pulmonary disease	0.00449	0.109	CbGeAlD
Perphenazine—HTR2A—pulmonary artery—chronic obstructive pulmonary disease	0.0028	0.0681	CbGeAlD
Perphenazine—Ileus paralytic—Tiotropium—chronic obstructive pulmonary disease	0.00223	0.0254	CcSEcCtD
Perphenazine—Excitement—Aminophylline—chronic obstructive pulmonary disease	0.00209	0.0238	CcSEcCtD
Perphenazine—Inappropriate antidiuretic hormone secretion—Aminophylline—chronic obstructive pulmonary disease	0.00176	0.0201	CcSEcCtD
Perphenazine—Excitement—Salbutamol—chronic obstructive pulmonary disease	0.0015	0.0171	CcSEcCtD
Perphenazine—CYP2C18—bronchus—chronic obstructive pulmonary disease	0.00143	0.0347	CbGeAlD
Perphenazine—Gynaecomastia—Roflumilast—chronic obstructive pulmonary disease	0.00137	0.0157	CcSEcCtD
Perphenazine—Glaucoma—Tiotropium—chronic obstructive pulmonary disease	0.00128	0.0146	CcSEcCtD
Perphenazine—Glaucoma—Formoterol—chronic obstructive pulmonary disease	0.00104	0.0118	CcSEcCtD
Perphenazine—Glaucoma—Arformoterol—chronic obstructive pulmonary disease	0.00104	0.0118	CcSEcCtD
Perphenazine—Dermatitis contact—Aminophylline—chronic obstructive pulmonary disease	0.00101	0.0115	CcSEcCtD
Perphenazine—Glycosuria—Formoterol—chronic obstructive pulmonary disease	0.000962	0.011	CcSEcCtD
Perphenazine—Glycosuria—Arformoterol—chronic obstructive pulmonary disease	0.000962	0.011	CcSEcCtD
Perphenazine—Mydriasis—Salbutamol—chronic obstructive pulmonary disease	0.000923	0.0105	CcSEcCtD
Perphenazine—Glycosuria—Salbutamol—chronic obstructive pulmonary disease	0.000909	0.0104	CcSEcCtD
Perphenazine—Liver injury—Montelukast—chronic obstructive pulmonary disease	0.000908	0.0103	CcSEcCtD
Perphenazine—AOX1—bronchus—chronic obstructive pulmonary disease	0.000903	0.022	CbGeAlD
Perphenazine—Pallor—Salbutamol—chronic obstructive pulmonary disease	0.000888	0.0101	CcSEcCtD
Perphenazine—Polyuria—Aminophylline—chronic obstructive pulmonary disease	0.000847	0.00965	CcSEcCtD
Perphenazine—CALM3—bronchus—chronic obstructive pulmonary disease	0.000814	0.0198	CbGeAlD
Perphenazine—AOX1—trachea—chronic obstructive pulmonary disease	0.000811	0.0197	CbGeAlD
Perphenazine—CALM3—smooth muscle tissue—chronic obstructive pulmonary disease	0.000796	0.0194	CbGeAlD
Perphenazine—Dermatitis exfoliative—Aminophylline—chronic obstructive pulmonary disease	0.000788	0.00898	CcSEcCtD
Perphenazine—CALM2—respiratory system—chronic obstructive pulmonary disease	0.000776	0.0189	CbGeAlD
Perphenazine—CALM1—respiratory system—chronic obstructive pulmonary disease	0.000773	0.0188	CbGeAlD
Perphenazine—Dermatitis contact—Arformoterol—chronic obstructive pulmonary disease	0.000771	0.00878	CcSEcCtD
Perphenazine—Dermatitis contact—Formoterol—chronic obstructive pulmonary disease	0.000771	0.00878	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Aminophylline—chronic obstructive pulmonary disease	0.000768	0.00875	CcSEcCtD
Perphenazine—Hepatocellular injury—Montelukast—chronic obstructive pulmonary disease	0.000764	0.0087	CcSEcCtD
Perphenazine—HTR7—respiratory system—chronic obstructive pulmonary disease	0.000755	0.0184	CbGeAlD
Perphenazine—CALM3—trachea—chronic obstructive pulmonary disease	0.000731	0.0178	CbGeAlD
Perphenazine—DRD2—respiratory system—chronic obstructive pulmonary disease	0.000714	0.0174	CbGeAlD
Perphenazine—Urinary retention—Aminophylline—chronic obstructive pulmonary disease	0.000707	0.00806	CcSEcCtD
Perphenazine—CALM2—connective tissue—chronic obstructive pulmonary disease	0.000683	0.0166	CbGeAlD
Perphenazine—CALM1—connective tissue—chronic obstructive pulmonary disease	0.00068	0.0166	CbGeAlD
Perphenazine—Urinary retention—Tiotropium—chronic obstructive pulmonary disease	0.000667	0.0076	CcSEcCtD
Perphenazine—Hyperkinesia—Montelukast—chronic obstructive pulmonary disease	0.000666	0.00759	CcSEcCtD
Perphenazine—HTR7—connective tissue—chronic obstructive pulmonary disease	0.000665	0.0162	CbGeAlD
Perphenazine—Muscle spasms—Roflumilast—chronic obstructive pulmonary disease	0.000646	0.00735	CcSEcCtD
Perphenazine—Hyperkinesia—Salbutamol—chronic obstructive pulmonary disease	0.000642	0.00731	CcSEcCtD
Perphenazine—CALM2—bronchus—chronic obstructive pulmonary disease	0.000639	0.0156	CbGeAlD
Perphenazine—CALM1—bronchus—chronic obstructive pulmonary disease	0.000636	0.0155	CbGeAlD
Perphenazine—CALM2—smooth muscle tissue—chronic obstructive pulmonary disease	0.000625	0.0152	CbGeAlD
Perphenazine—CALM1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000622	0.0151	CbGeAlD
Perphenazine—Nasal congestion—Arformoterol—chronic obstructive pulmonary disease	0.000621	0.00708	CcSEcCtD
Perphenazine—Nasal congestion—Formoterol—chronic obstructive pulmonary disease	0.000621	0.00708	CcSEcCtD
Perphenazine—Eczema—Montelukast—chronic obstructive pulmonary disease	0.000617	0.00703	CcSEcCtD
Perphenazine—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.000614	0.00699	CcSEcCtD
Perphenazine—HTR7—smooth muscle tissue—chronic obstructive pulmonary disease	0.000608	0.0148	CbGeAlD
Perphenazine—Dysphagia—Tiotropium—chronic obstructive pulmonary disease	0.000606	0.0069	CcSEcCtD
Perphenazine—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.000602	0.0147	CbGeAlD
Perphenazine—Eczema—Salbutamol—chronic obstructive pulmonary disease	0.000595	0.00677	CcSEcCtD
Perphenazine—Nasal congestion—Salbutamol—chronic obstructive pulmonary disease	0.000587	0.00668	CcSEcCtD
Perphenazine—AOX1—lung—chronic obstructive pulmonary disease	0.000583	0.0142	CbGeAlD
Perphenazine—Hypoglycaemia—Arformoterol—chronic obstructive pulmonary disease	0.00058	0.00661	CcSEcCtD
Perphenazine—Hypoglycaemia—Formoterol—chronic obstructive pulmonary disease	0.00058	0.00661	CcSEcCtD
Perphenazine—Hyperglycaemia—Aminophylline—chronic obstructive pulmonary disease	0.00058	0.0066	CcSEcCtD
Perphenazine—CYP2B6—respiratory system—chronic obstructive pulmonary disease	0.000577	0.014	CbGeAlD
Perphenazine—CALM2—trachea—chronic obstructive pulmonary disease	0.000574	0.014	CbGeAlD
Perphenazine—CALM1—trachea—chronic obstructive pulmonary disease	0.000571	0.0139	CbGeAlD
Perphenazine—HRH1—respiratory system—chronic obstructive pulmonary disease	0.000564	0.0137	CbGeAlD
Perphenazine—Glaucoma—Prednisolone—chronic obstructive pulmonary disease	0.000561	0.00639	CcSEcCtD
Perphenazine—HTR7—trachea—chronic obstructive pulmonary disease	0.000558	0.0136	CbGeAlD
Perphenazine—Hypoglycaemia—Salbutamol—chronic obstructive pulmonary disease	0.000548	0.00624	CcSEcCtD
Perphenazine—Hyperglycaemia—Tiotropium—chronic obstructive pulmonary disease	0.000547	0.00623	CcSEcCtD
Perphenazine—Infection—Roflumilast—chronic obstructive pulmonary disease	0.000545	0.0062	CcSEcCtD
Perphenazine—Mydriasis—Prednisolone—chronic obstructive pulmonary disease	0.000529	0.00603	CcSEcCtD
Perphenazine—CALM3—lung—chronic obstructive pulmonary disease	0.000525	0.0128	CbGeAlD
Perphenazine—Ataxia—Salbutamol—chronic obstructive pulmonary disease	0.000503	0.00572	CcSEcCtD
Perphenazine—HRH1—connective tissue—chronic obstructive pulmonary disease	0.000496	0.0121	CbGeAlD
Perphenazine—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.000496	0.00565	CcSEcCtD
Perphenazine—Asthma—Formoterol—chronic obstructive pulmonary disease	0.000489	0.00557	CcSEcCtD
Perphenazine—Asthma—Arformoterol—chronic obstructive pulmonary disease	0.000489	0.00557	CcSEcCtD
Perphenazine—ADRA2A—connective tissue—chronic obstructive pulmonary disease	0.000487	0.0119	CbGeAlD
Perphenazine—Asthma—Montelukast—chronic obstructive pulmonary disease	0.000479	0.00546	CcSEcCtD
Perphenazine—Oedema peripheral—Tiotropium—chronic obstructive pulmonary disease	0.000478	0.00544	CcSEcCtD
Perphenazine—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.000476	0.00543	CcSEcCtD
Perphenazine—CYP2B6—bronchus—chronic obstructive pulmonary disease	0.000475	0.0116	CbGeAlD
Perphenazine—Eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.000474	0.0054	CcSEcCtD
Perphenazine—HTR2A—respiratory system—chronic obstructive pulmonary disease	0.000471	0.0115	CbGeAlD
Perphenazine—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.000469	0.00534	CcSEcCtD
Perphenazine—Asthma—Salbutamol—chronic obstructive pulmonary disease	0.000462	0.00526	CcSEcCtD
Perphenazine—ADRA2A—bronchus—chronic obstructive pulmonary disease	0.000456	0.0111	CbGeAlD
Perphenazine—HRH1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000454	0.011	CbGeAlD
Perphenazine—Hyperglycaemia—Formoterol—chronic obstructive pulmonary disease	0.000441	0.00503	CcSEcCtD
Perphenazine—Hyperglycaemia—Arformoterol—chronic obstructive pulmonary disease	0.000441	0.00503	CcSEcCtD
Perphenazine—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000435	0.00496	CcSEcCtD
Perphenazine—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.000427	0.00487	CcSEcCtD
Perphenazine—Hyperglycaemia—Salbutamol—chronic obstructive pulmonary disease	0.000417	0.00475	CcSEcCtD
Perphenazine—HRH1—trachea—chronic obstructive pulmonary disease	0.000417	0.0101	CbGeAlD
Perphenazine—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.000416	0.00474	CcSEcCtD
Perphenazine—HTR2A—connective tissue—chronic obstructive pulmonary disease	0.000414	0.0101	CbGeAlD
Perphenazine—CALM2—lung—chronic obstructive pulmonary disease	0.000412	0.01	CbGeAlD
Perphenazine—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.000412	0.00469	CcSEcCtD
Perphenazine—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.000412	0.00469	CcSEcCtD
Perphenazine—CALM1—lung—chronic obstructive pulmonary disease	0.00041	0.00999	CbGeAlD
Perphenazine—ADRA2A—trachea—chronic obstructive pulmonary disease	0.000409	0.00996	CbGeAlD
Perphenazine—Glaucoma—Prednisone—chronic obstructive pulmonary disease	0.000408	0.00464	CcSEcCtD
Perphenazine—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000404	0.0046	CcSEcCtD
Perphenazine—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.000401	0.00457	CcSEcCtD
Perphenazine—HTR7—lung—chronic obstructive pulmonary disease	0.000401	0.00976	CbGeAlD
Perphenazine—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.000398	0.00453	CcSEcCtD
Perphenazine—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.000388	0.00442	CcSEcCtD
Perphenazine—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.000386	0.0044	CcSEcCtD
Perphenazine—Oedema peripheral—Formoterol—chronic obstructive pulmonary disease	0.000386	0.00439	CcSEcCtD
Perphenazine—Oedema peripheral—Arformoterol—chronic obstructive pulmonary disease	0.000386	0.00439	CcSEcCtD
Perphenazine—Hypoaesthesia—Montelukast—chronic obstructive pulmonary disease	0.000382	0.00435	CcSEcCtD
Perphenazine—HTR2A—smooth muscle tissue—chronic obstructive pulmonary disease	0.000379	0.00923	CbGeAlD
Perphenazine—DRD2—lung—chronic obstructive pulmonary disease	0.000379	0.00923	CbGeAlD
Perphenazine—Glycosuria—Prednisone—chronic obstructive pulmonary disease	0.000379	0.00431	CcSEcCtD
Perphenazine—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.000379	0.00431	CcSEcCtD
Perphenazine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000375	0.00427	CcSEcCtD
Perphenazine—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.000371	0.00423	CcSEcCtD
Perphenazine—Cough—Tiotropium—chronic obstructive pulmonary disease	0.000369	0.0042	CcSEcCtD
Perphenazine—Hypoaesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000368	0.00419	CcSEcCtD
Perphenazine—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000366	0.00416	CcSEcCtD
Perphenazine—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.000365	0.00415	CcSEcCtD
Perphenazine—Infection—Aminophylline—chronic obstructive pulmonary disease	0.000363	0.00414	CcSEcCtD
Perphenazine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000362	0.00413	CcSEcCtD
Perphenazine—Shock—Aminophylline—chronic obstructive pulmonary disease	0.00036	0.0041	CcSEcCtD
Perphenazine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000357	0.00406	CcSEcCtD
Perphenazine—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.000352	0.00401	CcSEcCtD
Perphenazine—Amenorrhoea—Prednisone—chronic obstructive pulmonary disease	0.000349	0.00398	CcSEcCtD
Perphenazine—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000348	0.00397	CcSEcCtD
Perphenazine—HTR2A—trachea—chronic obstructive pulmonary disease	0.000348	0.00847	CbGeAlD
Perphenazine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000343	0.00391	CcSEcCtD
Perphenazine—Infection—Tiotropium—chronic obstructive pulmonary disease	0.000342	0.0039	CcSEcCtD
Perphenazine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000342	0.00389	CcSEcCtD
Perphenazine—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000339	0.00386	CcSEcCtD
Perphenazine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000336	0.00383	CcSEcCtD
Perphenazine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000331	0.00377	CcSEcCtD
Perphenazine—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000328	0.00373	CcSEcCtD
Perphenazine—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000328	0.00373	CcSEcCtD
Perphenazine—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000321	0.00366	CcSEcCtD
Perphenazine—CYP1A2—lung—chronic obstructive pulmonary disease	0.00032	0.00778	CbGeAlD
Perphenazine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000318	0.00362	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.000317	0.00361	CcSEcCtD
Perphenazine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000313	0.00357	CcSEcCtD
Perphenazine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000313	0.00357	CcSEcCtD
Perphenazine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000312	0.00355	CcSEcCtD
Perphenazine—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000311	0.00355	CcSEcCtD
Perphenazine—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000311	0.00355	CcSEcCtD
Perphenazine—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000309	0.00352	CcSEcCtD
Perphenazine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000307	0.00349	CcSEcCtD
Perphenazine—CYP2B6—lung—chronic obstructive pulmonary disease	0.000306	0.00746	CbGeAlD
Perphenazine—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000305	0.00347	CcSEcCtD
Perphenazine—HRH1—lung—chronic obstructive pulmonary disease	0.000299	0.00729	CbGeAlD
Perphenazine—Cough—Formoterol—chronic obstructive pulmonary disease	0.000297	0.00339	CcSEcCtD
Perphenazine—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000297	0.00339	CcSEcCtD
Perphenazine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000296	0.00337	CcSEcCtD
Perphenazine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000295	0.00336	CcSEcCtD
Perphenazine—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000294	0.00335	CcSEcCtD
Perphenazine—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000294	0.00335	CcSEcCtD
Perphenazine—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000294	0.00335	CcSEcCtD
Perphenazine—ADRA2A—lung—chronic obstructive pulmonary disease	0.000294	0.00716	CbGeAlD
Perphenazine—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.000291	0.00332	CcSEcCtD
Perphenazine—Cough—Montelukast—chronic obstructive pulmonary disease	0.000291	0.00332	CcSEcCtD
Perphenazine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00029	0.00331	CcSEcCtD
Perphenazine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000289	0.00329	CcSEcCtD
Perphenazine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000289	0.00329	CcSEcCtD
Perphenazine—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000289	0.00329	CcSEcCtD
Perphenazine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000284	0.00323	CcSEcCtD
Perphenazine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000284	0.00323	CcSEcCtD
Perphenazine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000283	0.00322	CcSEcCtD
Perphenazine—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000281	0.0032	CcSEcCtD
Perphenazine—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000278	0.00317	CcSEcCtD
Perphenazine—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000278	0.00317	CcSEcCtD
Perphenazine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000278	0.00317	CcSEcCtD
Perphenazine—Infection—Formoterol—chronic obstructive pulmonary disease	0.000276	0.00315	CcSEcCtD
Perphenazine—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000276	0.00315	CcSEcCtD
Perphenazine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000274	0.00312	CcSEcCtD
Perphenazine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000272	0.0031	CcSEcCtD
Perphenazine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000272	0.00309	CcSEcCtD
Perphenazine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000272	0.00309	CcSEcCtD
Perphenazine—Infection—Montelukast—chronic obstructive pulmonary disease	0.000271	0.00308	CcSEcCtD
Perphenazine—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.00027	0.00308	CcSEcCtD
Perphenazine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000269	0.00307	CcSEcCtD
Perphenazine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000268	0.00305	CcSEcCtD
Perphenazine—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000268	0.00305	CcSEcCtD
Perphenazine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000263	0.00299	CcSEcCtD
Perphenazine—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000261	0.00297	CcSEcCtD
Perphenazine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00026	0.00296	CcSEcCtD
Perphenazine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00026	0.00296	CcSEcCtD
Perphenazine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000259	0.00295	CcSEcCtD
Perphenazine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000258	0.00294	CcSEcCtD
Perphenazine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000256	0.00292	CcSEcCtD
Perphenazine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000254	0.00289	CcSEcCtD
Perphenazine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000252	0.00287	CcSEcCtD
Perphenazine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000252	0.00287	CcSEcCtD
Perphenazine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00025	0.00285	CcSEcCtD
Perphenazine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00025	0.00285	CcSEcCtD
Perphenazine—HTR2A—lung—chronic obstructive pulmonary disease	0.00025	0.00608	CbGeAlD
Perphenazine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000248	0.00283	CcSEcCtD
Perphenazine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000248	0.00283	CcSEcCtD
Perphenazine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000247	0.00282	CcSEcCtD
Perphenazine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000247	0.00282	CcSEcCtD
Perphenazine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000246	0.00281	CcSEcCtD
Perphenazine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000245	0.0028	CcSEcCtD
Perphenazine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000244	0.00278	CcSEcCtD
Perphenazine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000242	0.00276	CcSEcCtD
Perphenazine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000242	0.00275	CcSEcCtD
Perphenazine—Pain—Formoterol—chronic obstructive pulmonary disease	0.000238	0.00271	CcSEcCtD
Perphenazine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000238	0.00271	CcSEcCtD
Perphenazine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000238	0.00271	CcSEcCtD
Perphenazine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000238	0.00271	CcSEcCtD
Perphenazine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000238	0.00271	CcSEcCtD
Perphenazine—Flupentixol—HTR2A—chronic obstructive pulmonary disease	0.000235	0.0492	CrCbGaD
Perphenazine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000234	0.00267	CcSEcCtD
Perphenazine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000234	0.00266	CcSEcCtD
Perphenazine—Pain—Montelukast—chronic obstructive pulmonary disease	0.000233	0.00265	CcSEcCtD
Perphenazine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000229	0.00261	CcSEcCtD
Perphenazine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000228	0.0026	CcSEcCtD
Perphenazine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000228	0.0026	CcSEcCtD
Perphenazine—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000227	0.00259	CcSEcCtD
Perphenazine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000225	0.00256	CcSEcCtD
Perphenazine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000225	0.00256	CcSEcCtD
Perphenazine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000221	0.00252	CcSEcCtD
Perphenazine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000221	0.00252	CcSEcCtD
Perphenazine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00022	0.0025	CcSEcCtD
Perphenazine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00022	0.0025	CcSEcCtD
Perphenazine—Clomipramine—GSTP1—chronic obstructive pulmonary disease	0.000218	0.0458	CrCbGaD
Perphenazine—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000218	0.00248	CcSEcCtD
Perphenazine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000216	0.00247	CcSEcCtD
Perphenazine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000216	0.00246	CcSEcCtD
Perphenazine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000216	0.00246	CcSEcCtD
Perphenazine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000215	0.00245	CcSEcCtD
Perphenazine—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000212	0.00241	CcSEcCtD
Perphenazine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000209	0.00238	CcSEcCtD
Perphenazine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000208	0.00237	CcSEcCtD
Perphenazine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000205	0.00233	CcSEcCtD
Perphenazine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000205	0.00233	CcSEcCtD
Perphenazine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000201	0.00229	CcSEcCtD
Perphenazine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000197	0.00224	CcSEcCtD
Perphenazine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000197	0.00224	CcSEcCtD
Perphenazine—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000196	0.00224	CcSEcCtD
Perphenazine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000194	0.0022	CcSEcCtD
Perphenazine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000193	0.0022	CcSEcCtD
Perphenazine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00019	0.00217	CcSEcCtD
Perphenazine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00019	0.00217	CcSEcCtD
Perphenazine—Domperidone—CYP1A2—chronic obstructive pulmonary disease	0.000187	0.0392	CrCbGaD
Perphenazine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000186	0.00212	CcSEcCtD
Perphenazine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000186	0.00212	CcSEcCtD
Perphenazine—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000185	0.0021	CcSEcCtD
Perphenazine—Cyamemazine—HTR2A—chronic obstructive pulmonary disease	0.000184	0.0386	CrCbGaD
Perphenazine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000184	0.0021	CcSEcCtD
Perphenazine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000184	0.0021	CcSEcCtD
Perphenazine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00018	0.00205	CcSEcCtD
Perphenazine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00018	0.00205	CcSEcCtD
Perphenazine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000174	0.00199	CcSEcCtD
Perphenazine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000174	0.00199	CcSEcCtD
Perphenazine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000174	0.00198	CcSEcCtD
Perphenazine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000174	0.00198	CcSEcCtD
Perphenazine—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000174	0.00198	CcSEcCtD
Perphenazine—Nefazodone—SLC6A4—chronic obstructive pulmonary disease	0.000171	0.0358	CrCbGaD
Perphenazine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000171	0.00194	CcSEcCtD
Perphenazine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000169	0.00192	CcSEcCtD
Perphenazine—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000166	0.00189	CcSEcCtD
Perphenazine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000165	0.00187	CcSEcCtD
Perphenazine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000162	0.00185	CcSEcCtD
Perphenazine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.00016	0.00182	CcSEcCtD
Perphenazine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000159	0.00182	CcSEcCtD
Perphenazine—Aripiprazole—SLC6A4—chronic obstructive pulmonary disease	0.000159	0.0333	CrCbGaD
Perphenazine—Trazodone—SLC6A4—chronic obstructive pulmonary disease	0.000158	0.0331	CrCbGaD
Perphenazine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000157	0.00179	CcSEcCtD
Perphenazine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000151	0.00172	CcSEcCtD
Perphenazine—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000148	0.00169	CcSEcCtD
Perphenazine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000147	0.00167	CcSEcCtD
Perphenazine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000136	0.00155	CcSEcCtD
Perphenazine—Thiothixene—CYP1A2—chronic obstructive pulmonary disease	0.000135	0.0283	CrCbGaD
Perphenazine—Pipotiazine—CYP1A2—chronic obstructive pulmonary disease	0.000135	0.0283	CrCbGaD
Perphenazine—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000134	0.00153	CcSEcCtD
Perphenazine—Zuclopenthixol—HTR2A—chronic obstructive pulmonary disease	0.000132	0.0277	CrCbGaD
Perphenazine—Nefazodone—HTR2A—chronic obstructive pulmonary disease	0.000131	0.0275	CrCbGaD
Perphenazine—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000129	0.00147	CcSEcCtD
Perphenazine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000126	0.00144	CcSEcCtD
Perphenazine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000123	0.0014	CcSEcCtD
Perphenazine—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000123	0.0014	CcSEcCtD
Perphenazine—Aripiprazole—HTR2A—chronic obstructive pulmonary disease	0.000122	0.0256	CrCbGaD
Perphenazine—Trazodone—HTR2A—chronic obstructive pulmonary disease	0.000121	0.0254	CrCbGaD
Perphenazine—Syncope—Prednisone—chronic obstructive pulmonary disease	0.00012	0.00137	CcSEcCtD
Perphenazine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00012	0.00136	CcSEcCtD
Perphenazine—Acepromazine—HTR2A—chronic obstructive pulmonary disease	0.000118	0.0248	CrCbGaD
Perphenazine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000118	0.00134	CcSEcCtD
Perphenazine—Clomipramine—SLC6A4—chronic obstructive pulmonary disease	0.000117	0.0245	CrCbGaD
Perphenazine—Fluphenazine—CYP1A2—chronic obstructive pulmonary disease	0.000117	0.0244	CrCbGaD
Perphenazine—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000116	0.00132	CcSEcCtD
Perphenazine—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000116	0.00132	CcSEcCtD
Perphenazine—Thioproperazine—HTR2A—chronic obstructive pulmonary disease	0.000116	0.0242	CrCbGaD
Perphenazine—Pipotiazine—HTR2A—chronic obstructive pulmonary disease	0.000114	0.0238	CrCbGaD
Perphenazine—Thiothixene—HTR2A—chronic obstructive pulmonary disease	0.000114	0.0238	CrCbGaD
Perphenazine—Mesoridazine—HTR2A—chronic obstructive pulmonary disease	0.000112	0.0235	CrCbGaD
Perphenazine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.00126	CcSEcCtD
Perphenazine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000109	0.00125	CcSEcCtD
Perphenazine—Infection—Prednisone—chronic obstructive pulmonary disease	0.000109	0.00124	CcSEcCtD
Perphenazine—Shock—Prednisone—chronic obstructive pulmonary disease	0.000108	0.00123	CcSEcCtD
Perphenazine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000107	0.00122	CcSEcCtD
Perphenazine—Clomipramine—CYP1A2—chronic obstructive pulmonary disease	0.000107	0.0223	CrCbGaD
Perphenazine—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000104	0.00119	CcSEcCtD
Perphenazine—Thioridazine—CYP1A2—chronic obstructive pulmonary disease	0.0001	0.021	CrCbGaD
Perphenazine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	9.96e-05	0.00113	CcSEcCtD
Perphenazine—Insomnia—Prednisone—chronic obstructive pulmonary disease	9.9e-05	0.00113	CcSEcCtD
Perphenazine—Fluphenazine—HTR2A—chronic obstructive pulmonary disease	9.84e-05	0.0206	CrCbGaD
Perphenazine—Methotrimeprazine—CYP1A2—chronic obstructive pulmonary disease	9.59e-05	0.0201	CrCbGaD
Perphenazine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	9.52e-05	0.00108	CcSEcCtD
Perphenazine—Propiomazine—HTR2A—chronic obstructive pulmonary disease	9.46e-05	0.0198	CrCbGaD
Perphenazine—Headache—Prednisolone—chronic obstructive pulmonary disease	9.44e-05	0.00108	CcSEcCtD
Perphenazine—Constipation—Prednisone—chronic obstructive pulmonary disease	9.36e-05	0.00107	CcSEcCtD
Perphenazine—Trifluoperazine—CYP1A2—chronic obstructive pulmonary disease	9.32e-05	0.0195	CrCbGaD
Perphenazine—Clomipramine—HTR2A—chronic obstructive pulmonary disease	9e-05	0.0188	CrCbGaD
Perphenazine—Chlorprothixene—HTR2A—chronic obstructive pulmonary disease	8.96e-05	0.0188	CrCbGaD
Perphenazine—Urticaria—Prednisone—chronic obstructive pulmonary disease	8.7e-05	0.000991	CcSEcCtD
Perphenazine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	8.65e-05	0.000986	CcSEcCtD
Perphenazine—Thioridazine—HTR2A—chronic obstructive pulmonary disease	8.48e-05	0.0178	CrCbGaD
Perphenazine—Promazine—CYP1A2—chronic obstructive pulmonary disease	8.31e-05	0.0174	CrCbGaD
Perphenazine—Acepromazine—ALB—chronic obstructive pulmonary disease	8.1e-05	0.017	CrCbGaD
Perphenazine—Methotrimeprazine—HTR2A—chronic obstructive pulmonary disease	8.09e-05	0.017	CrCbGaD
Perphenazine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	8.07e-05	0.000919	CcSEcCtD
Perphenazine—Promethazine—HTR2A—chronic obstructive pulmonary disease	7.97e-05	0.0167	CrCbGaD
Perphenazine—Thioproperazine—ALB—chronic obstructive pulmonary disease	7.92e-05	0.0166	CrCbGaD
Perphenazine—Trifluoperazine—HTR2A—chronic obstructive pulmonary disease	7.86e-05	0.0165	CrCbGaD
Perphenazine—Thiothixene—ALB—chronic obstructive pulmonary disease	7.79e-05	0.0163	CrCbGaD
Perphenazine—Pipotiazine—ALB—chronic obstructive pulmonary disease	7.79e-05	0.0163	CrCbGaD
Perphenazine—Pruritus—Prednisone—chronic obstructive pulmonary disease	7.75e-05	0.000882	CcSEcCtD
Perphenazine—Quetiapine—HTR2A—chronic obstructive pulmonary disease	7.63e-05	0.016	CrCbGaD
Perphenazine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	7.49e-05	0.000853	CcSEcCtD
Perphenazine—Chlorpromazine—CYP1A2—chronic obstructive pulmonary disease	7.31e-05	0.0153	CrCbGaD
Perphenazine—Dizziness—Prednisone—chronic obstructive pulmonary disease	7.24e-05	0.000825	CcSEcCtD
Perphenazine—Promazine—HTR2A—chronic obstructive pulmonary disease	7.01e-05	0.0147	CrCbGaD
Perphenazine—Headache—Prednisone—chronic obstructive pulmonary disease	6.86e-05	0.000781	CcSEcCtD
Perphenazine—Chlorpromazine—HTR2A—chronic obstructive pulmonary disease	6.17e-05	0.0129	CrCbGaD
Perphenazine—Clomipramine—ALB—chronic obstructive pulmonary disease	6.16e-05	0.0129	CrCbGaD
Perphenazine—Chlorpromazine—ALB—chronic obstructive pulmonary disease	4.22e-05	0.00885	CrCbGaD
Perphenazine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.86e-06	7.36e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.85e-06	7.35e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	6.83e-06	7.32e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.82e-06	7.31e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.81e-06	7.3e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.8e-06	7.29e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.76e-06	7.24e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.75e-06	7.24e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.75e-06	7.24e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	6.74e-06	7.23e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	6.74e-06	7.23e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—NOS2—chronic obstructive pulmonary disease	6.74e-06	7.23e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Hemostasis—TP53—chronic obstructive pulmonary disease	6.68e-06	7.16e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.67e-06	7.15e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.55e-06	7.02e-05	CbGpPWpGaD
Perphenazine—CALM3—Innate Immune System—EGFR—chronic obstructive pulmonary disease	6.54e-06	7.01e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—NOS2—chronic obstructive pulmonary disease	6.52e-06	6.99e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—NOS2—chronic obstructive pulmonary disease	6.52e-06	6.99e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.45e-06	6.91e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.45e-06	6.91e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.41e-06	6.87e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.34e-06	6.8e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.34e-06	6.79e-05	CbGpPWpGaD
Perphenazine—CALM1—Innate Immune System—EGFR—chronic obstructive pulmonary disease	6.32e-06	6.78e-05	CbGpPWpGaD
Perphenazine—CALM2—Innate Immune System—EGFR—chronic obstructive pulmonary disease	6.32e-06	6.78e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	6.31e-06	6.76e-05	CbGpPWpGaD
Perphenazine—CALM3—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	6.28e-06	6.73e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.25e-06	6.7e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	6.23e-06	6.68e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.22e-06	6.67e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.21e-06	6.65e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.2e-06	6.65e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.16e-06	6.6e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.14e-06	6.58e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.1e-06	6.54e-05	CbGpPWpGaD
Perphenazine—CALM3—Hemostasis—TP53—chronic obstructive pulmonary disease	6.09e-06	6.53e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.09e-06	6.53e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.07e-06	6.51e-05	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	6.07e-06	6.51e-05	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	6.07e-06	6.51e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.03e-06	6.47e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	6.03e-06	6.46e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	6.03e-06	6.46e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.02e-06	6.46e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.97e-06	6.4e-05	CbGpPWpGaD
Perphenazine—CALM1—Hemostasis—TP53—chronic obstructive pulmonary disease	5.9e-06	6.32e-05	CbGpPWpGaD
Perphenazine—CALM2—Hemostasis—TP53—chronic obstructive pulmonary disease	5.9e-06	6.32e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.81e-06	6.23e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.78e-06	6.2e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.74e-06	6.15e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.73e-06	6.14e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.72e-06	6.14e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.72e-06	6.13e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	5.7e-06	6.11e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—SERPINE1—chronic obstructive pulmonary disease	5.68e-06	6.09e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.67e-06	6.08e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.66e-06	6.07e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.64e-06	6.05e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.6e-06	6e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.55e-06	5.95e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.54e-06	5.94e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.52e-06	5.91e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	5.51e-06	5.91e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	5.51e-06	5.91e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—SERPINE1—chronic obstructive pulmonary disease	5.49e-06	5.89e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—SERPINE1—chronic obstructive pulmonary disease	5.49e-06	5.89e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.48e-06	5.87e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.48e-06	5.87e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.46e-06	5.85e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.45e-06	5.84e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.42e-06	5.81e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—NOS3—chronic obstructive pulmonary disease	5.42e-06	5.81e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.4e-06	5.79e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	5.34e-06	5.72e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.29e-06	5.67e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.27e-06	5.65e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.27e-06	5.65e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.27e-06	5.65e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.26e-06	5.64e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—NOS3—chronic obstructive pulmonary disease	5.24e-06	5.62e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—NOS3—chronic obstructive pulmonary disease	5.24e-06	5.62e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.21e-06	5.59e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—ALB—chronic obstructive pulmonary disease	5.2e-06	5.58e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.19e-06	5.57e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.15e-06	5.52e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.15e-06	5.52e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.1e-06	5.47e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.07e-06	5.43e-05	CbGpPWpGaD
Perphenazine—CALM3—Innate Immune System—IL6—chronic obstructive pulmonary disease	5.02e-06	5.39e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.02e-06	5.38e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.01e-06	5.37e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—IL1B—chronic obstructive pulmonary disease	5e-06	5.36e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.99e-06	5.35e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—NOS3—chronic obstructive pulmonary disease	4.98e-06	5.33e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.94e-06	5.3e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.94e-06	5.29e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.9e-06	5.25e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.9e-06	5.25e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	4.88e-06	5.23e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	4.87e-06	5.22e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.87e-06	5.22e-05	CbGpPWpGaD
Perphenazine—CALM2—Innate Immune System—IL6—chronic obstructive pulmonary disease	4.86e-06	5.21e-05	CbGpPWpGaD
Perphenazine—CALM1—Innate Immune System—IL6—chronic obstructive pulmonary disease	4.86e-06	5.21e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.85e-06	5.2e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—IL1B—chronic obstructive pulmonary disease	4.83e-06	5.18e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—IL1B—chronic obstructive pulmonary disease	4.83e-06	5.18e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.79e-06	5.14e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.78e-06	5.13e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.78e-06	5.12e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—ALB—chronic obstructive pulmonary disease	4.75e-06	5.09e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.73e-06	5.07e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.72e-06	5.06e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.7e-06	5.03e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.67e-06	5.01e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	4.66e-06	5e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.65e-06	4.98e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.64e-06	4.97e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.63e-06	4.97e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—ALB—chronic obstructive pulmonary disease	4.59e-06	4.92e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—ALB—chronic obstructive pulmonary disease	4.59e-06	4.92e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.57e-06	4.9e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.57e-06	4.9e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.56e-06	4.89e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—NOS3—chronic obstructive pulmonary disease	4.54e-06	4.87e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.49e-06	4.81e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.46e-06	4.79e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.46e-06	4.78e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.44e-06	4.76e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.43e-06	4.75e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.39e-06	4.71e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—NOS3—chronic obstructive pulmonary disease	4.39e-06	4.71e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.36e-06	4.67e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.25e-06	4.55e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.22e-06	4.53e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.22e-06	4.53e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.17e-06	4.47e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.16e-06	4.46e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	4.13e-06	4.43e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.12e-06	4.42e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.07e-06	4.36e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.06e-06	4.35e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.05e-06	4.34e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.03e-06	4.32e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.03e-06	4.32e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.99e-06	4.28e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.98e-06	4.26e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	3.95e-06	4.23e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.92e-06	4.2e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.89e-06	4.17e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.89e-06	4.17e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.86e-06	4.14e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.85e-06	4.13e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.85e-06	4.12e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.85e-06	4.12e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.81e-06	4.09e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—EGFR—chronic obstructive pulmonary disease	3.81e-06	4.08e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.8e-06	4.07e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.79e-06	4.07e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.74e-06	4.01e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.73e-06	4e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.69e-06	3.96e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.69e-06	3.96e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	3.68e-06	3.95e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—EGFR—chronic obstructive pulmonary disease	3.68e-06	3.95e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—EGFR—chronic obstructive pulmonary disease	3.68e-06	3.95e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.67e-06	3.94e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.67e-06	3.94e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.67e-06	3.93e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.66e-06	3.92e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—TGFB1—chronic obstructive pulmonary disease	3.58e-06	3.84e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.56e-06	3.82e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.56e-06	3.82e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	3.52e-06	3.78e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—EGFR—chronic obstructive pulmonary disease	3.51e-06	3.77e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.51e-06	3.76e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.5e-06	3.75e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.48e-06	3.73e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—TGFB1—chronic obstructive pulmonary disease	3.47e-06	3.72e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—TGFB1—chronic obstructive pulmonary disease	3.47e-06	3.72e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.44e-06	3.69e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.43e-06	3.68e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.41e-06	3.66e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—EGFR—chronic obstructive pulmonary disease	3.4e-06	3.64e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—EGFR—chronic obstructive pulmonary disease	3.4e-06	3.64e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	3.39e-06	3.63e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.37e-06	3.61e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	3.36e-06	3.6e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.35e-06	3.59e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.35e-06	3.59e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.34e-06	3.58e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.29e-06	3.53e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.29e-06	3.52e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.26e-06	3.5e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.26e-06	3.49e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.26e-06	3.49e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	3.24e-06	3.48e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	3.21e-06	3.45e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.2e-06	3.43e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.1e-06	3.32e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.1e-06	3.32e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.07e-06	3.29e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.07e-06	3.29e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.05e-06	3.27e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.02e-06	3.24e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.02e-06	3.23e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.01e-06	3.23e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3e-06	3.21e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.96e-06	3.18e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.96e-06	3.17e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.95e-06	3.16e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.95e-06	3.16e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—IL6—chronic obstructive pulmonary disease	2.93e-06	3.14e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.88e-06	3.09e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	2.87e-06	3.08e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.87e-06	3.07e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—IL6—chronic obstructive pulmonary disease	2.83e-06	3.03e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—IL6—chronic obstructive pulmonary disease	2.83e-06	3.03e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.75e-06	2.95e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.75e-06	2.94e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.73e-06	2.93e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—IL6—chronic obstructive pulmonary disease	2.7e-06	2.9e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.7e-06	2.89e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.65e-06	2.84e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.65e-06	2.84e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.64e-06	2.83e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.62e-06	2.81e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—IL6—chronic obstructive pulmonary disease	2.61e-06	2.8e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—IL6—chronic obstructive pulmonary disease	2.61e-06	2.8e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.53e-06	2.71e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.51e-06	2.69e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.49e-06	2.67e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.48e-06	2.66e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.46e-06	2.64e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.43e-06	2.6e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.43e-06	2.6e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.38e-06	2.55e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.38e-06	2.55e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.32e-06	2.48e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.28e-06	2.44e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.27e-06	2.44e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.26e-06	2.43e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.22e-06	2.38e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.12e-06	2.27e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.07e-06	2.22e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.07e-06	2.22e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2e-06	2.14e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2e-06	2.14e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.89e-06	2.03e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.83e-06	1.96e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.83e-06	1.96e-05	CbGpPWpGaD
